None of us could have anticipated the COVID-19 pandemic, and due to the pause on screenings, millions of mammograms have been deferred.
The AuntMinnie.com 2020 Virtual Conference takes place April 30 and May 1. The online experience will feature keynote presentations, webinars, interactive trade show booths, and live Q&A sessions focused on top industry subjects.
COVID 19 and Radiology: There's Never Been a Better Time for AI
The COVID 19 pandemic has already overwhelmed our healthcare system, creating a ripple effect that puts additional strain on radiologists—and this will have serious impacts on breast cancer patient outcomes. In order to enforce social distancing and preserve resources for critically ill coronavirus patients, many imaging centers have put routine scheduled screening mammograms on hold for now. However, this means that those imaging centers will soon have to deal with the challenge of managing backlogs, keeping up with patient demand and ensuring accuracy in diagnosis at the same time.
The AI-based mammography screening paper by Google scientists first published in Nature is bringing public awareness to one of the most promising fields of artificial intelligence, presenting the perfect opportunity for CureMetrix to highlight our AI-driven mammography solutions that are already in the market saving today. Highlighted in the Journal of Digital Imaging in April 2019, CureMetrix is currently being used to support radiologists in clinics in the US, Brazil, and Mexico.
Artificial Intelligence (AI) has arrived in radiology and is quickly moving from the lab to clinical use. A recent survey shows that healthcare executives are not only embracing the use of artificial intelligence, they’re making budgetary plans to bring the technology into their organizations.
We are honored to share the news that CureMetrix was selected by an esteemed panel of industry and clinical experts as the Best New Radiology Vendor for 2019 https://www.einpresswire.com/article/500004616/curemetrix-wins-best-new-radiology-vendor-of-the-year
Artificial intelligence (AI) in healthcare has evolved quickly, and today interest is surging. After its early days in R&D and testing, we’re now seeing the emergence of powerful FDA-cleared products with vast potential to reshape and enhance patient screening, diagnosis and treatment.